The Medical Advisor

An observational study presented at the 2016 American Society of Clinical Oncology annual meeting indicated that practicing Falun Gong could prolong the survival of patients with terminal cancer and alleviate their symptoms. Researchers from Switzerland, Taiwan, the UK, and the United States observed 152 terminal cancer patients in China who practiced Falun Gong. As of the report date, 149 patients were still alive and in good health. Compared to the predicted survival period of 5.1 months, their survival period was prolonged to 56 months. Notably, patients’ quality of life also improved significantly. A 2020 study involving more than 1,000 Taiwanese Falun Gong practitioners found that individuals with chronic conditions such as heart disease, diabetes, lung issues, and high blood pressure experienced a 70 percent to 89 percent improvement or recovery after practicing Falun Gong. Note: Falun Gong is an offshoot of qigong ( Britannica ). Advanced Stomach Cancer: A Specific Case Report

“I could not get any help despite being in the hospital. It was truly terrifying. My body felt like an instrument of torture, a prison trapping and tormenting me,” recalled Isabella Murphy, who once suffered from fibromyalgia. Originally from Taiwan, Ms. Murphy grew up in a happy family. She attended Taipei First Girls’ High School and later National Taiwan University. After graduating, she pursued two master’s degrees in biotechnology and computer engineering at the University of Connecticut. Ms. Murphy found a job before completing her master’s degrees and started a family in the United States. However, in 2005, a car accident turned her life upside down. Just a month after starting her job, she was rear-ended on her way home. Though she did not sustain any external injuries, she suffered from soft tissue injuries and a mild concussion. The doctors told her that no treatment was needed and that she would recover slowly. However, nine months later, her condition deteriorated, even aff

Recently I reported on a case of Stage IV Colon Cancer that appeared hopeless . The gentleman, Rick, had widespread metastatic disease affecting the liver and lymph nodes and was told his cancer was “unsurvivable.” At most, he had six months left, according to his oncologist. Following adding Ivermectin, his tumor markers dropped from 1489 to 4.7, and his metastases calcified and shrunk. This was believed due to the anti-metastatic effect of Ivermectin as it suppresses the WnT Pathway , which cancer stem cells rely upon.   Dr. Tess Lawrie recently reported on a case of ovarian metastatic cancer with subsequent involvement of the peritoneum – a common spread area. Despite an initial tumor marker (Ca125) level of 288, following Ivermectin and three (9 weeks) chemotherapy sessions, her Ca125 level dropped to 22. There was a substantial regression with no trace of tumor on the peritoneum. Related:  The Surprising Potential of Ivermectin Against Cancer: Dr. Kathleen Ruddy The surgeon was st